Episodes (Page 3)
01:01:48
✨
David Schenkein discusses GV's approach to biotech investing.
✨
Kevin Fitzgerald shares the history and evolution of RNAi medicines.
Kevin Fitzgerald
✨
Jonathan Bricker explains tech-assisted smoking cessation strategies.
Jonathan Bricker
✨
Leslie Williams introduces the concept of transfer RNA therapies.
Leslie Williams
✨
Chris Garcia details protein engineering for new drugs.
Chris Garcia
✨
Zach Hornby addresses the challenge of cancer drug resistance.
Zach Hornby
✨
Ted Love and Alan Anderson discuss improving sickle cell care.
Alan Anderson
Ted Love
✨
Sarah Boyce highlights RNA medicines for muscle diseases.
✨
Sean McClain explains AI's role in drug discovery.
✨
Jeff Stein discusses a novel long-lasting flu drug.
✨
Abe Ceesay on precision medicine in neuroscience.
Abe Ceesay
✨
Jimi Olaghere shares his experience with CRISPR therapy.
Jimi Olaghere
✨
David Younger and Randolph Lopez on SynBio and AI.
David Younger
Randolph Lopez
✨
Vineeta Agarwala discusses A16Z's AI in drug discovery investments.
✨
David Liu introduces new tools for biological research.
David Liu
✨
Valerie Daggett on early Alzheimer's detection and treatment.
Valerie Daggett
✨
Robert Ang explains CRISPR for bone marrow transplants.
Robert Ang
✨
Rick Young on studying gene expression for drug discovery.
Rick Young
✨
Jens Eckstein discusses investing in healthy aging.